Hudson Bay Capital Management LP Astrazeneca PLC Transaction History
Hudson Bay Capital Management LP
- $24.1 Billion
- Q4 2024
A detailed history of Hudson Bay Capital Management LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 85,200 shares of AZN stock, worth $6.45 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
85,200
Previous 35,000
143.43%
Holding current value
$6.45 Million
Previous $2.73 Million
104.69%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.57 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.1 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.84 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.8 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.82 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...